Biodyne Co., Ltd. (KOSDAQ:314930)
14,350
-120 (-0.83%)
At close: Feb 6, 2026
Biodyne Company Description
Biodyne Co., Ltd. engages in the development, manufacture, and sale of liquid-based cytology (LBC) equipment and reagent kits for cancer diagnosis in South Korea.
The company offers PATHPLORER solution, which preserves and fixes the collected cells; PATHPLORER LBC system, an equipment for processing liquid cytology samples for cancer diagnosis.
It exports its products to Japan, Russia, Portugal, Thailand, and internationally. The company was founded in 1999 and is headquartered in Seoul, South Korea.
Biodyne Co., Ltd.
| Country | South Korea |
| Founded | 1999 |
| Industry | Surgical and Medical Instruments and Apparatus |
| CEO | Wook-bin Im |
Contact Details
Address: 24-4, Achasan-ro 5-gil Seoul, 04793 South Korea | |
| Phone | 82 1 522 4811 |
| Website | biodyne.asia |
Stock Details
| Ticker Symbol | 314930 |
| Exchange | KOSDAQ |
| Stock Type | Common Stock |
| Fiscal Year | January - December |
| Reporting Currency | KRW |
| SIC Code | 3841 |
Key Executives
| Name | Position |
|---|---|
| Wook-bin Im | Chief Executive Officer |
| GeunHo Yang | Chief Financial Officer |